SCHEMBL7973987

SCHEMBL7973987

CCC(=O)Nc1ncn(Cc2ccc(C)cc2)c1C(N)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.45
FGFR4 P22455 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.44
LMNA P02545 3/20 0.44
NPSR1 Q6W5P4 1/20 0.44
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
HTT P42858 1/20 0.39
NR3C1 P04150 1/20 0.39
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
SCD O00767 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC2 Q92769 2/20 0.37
PKM P14618 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991565 0.89 TSHR (0.49) FGFR1FGFR4SMN1; SMN2LMNAHTT
SCHEMBL7985495 0.88 CYP11B1 (0.39) FGFR1FGFR4SMN1; SMN2LMNANPSR1
SCHEMBL7988641 0.87 KMT2A (0.44) FGFR1FGFR4SMN1; SMN2LMNANPC1
SCHEMBL7984711 0.87 ABCC8 (0.44) FGFR1FGFR4NPC1RAB9ASCD
SCHEMBL7986400 0.86 YTHDC1 (0.47) FGFR1FGFR4SMN1; SMN2LMNANPSR1
SCHEMBL7987961 0.86 MAPT (0.47) LMNACYP11B1CYP11B2MAPTKMT2A
SCHEMBL7974324 0.84 TNF (0.44) SMN1; SMN2LMNANPC1RAB9AHTT
SCHEMBL7985508 0.83 ALDH1A1 (0.43) SMN1; SMN2LMNAHTTKMT2A
SCHEMBL7987598 0.83 RIOK2 (0.41) FGFR1FGFR4SMN1; SMN2RAB9AKMT2A
SCHEMBL7974162 0.83 KDM4E (0.52) FGFR1FGFR4SMN1; SMN2HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed